Physician profile
Saif Hassan
NPI 1124315114
$41,154.42
in general payments reported to CMS, 2019-2025
8 companies · $8,518 in 2025
The $8,518 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,128 · 2020: $8,687 · 2021: $5,262 · 2022: $74.46 · 2023: $13K · 2024: $1,035 · 2025: $8,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Food and Beverage: $1,365 · Travel and Lodging: $629 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $21,000.00 |
| Food and Beverage | $1,365.17 |
| Travel and Lodging | $629.06 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $40,226.45 | 2019-2025 | Da Vinci Surgical System, Davinci Xi |
| Tela Bio, INC. | $535.09 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $162.09 | 2019 | |
| Wound Management Technologies, INC | $89.04 | 2019 | |
| Allergan, INC. | $85.58 | 2020-2021 | |
| Conmed Corporation | $28.19 | 2021 | |
| Biom'Up France Sas | $15.98 | 2020 | |
| Baxter Healthcare | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saif Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.